05/29/2026 / By Douglas Harrington

Nearly two-thirds of Alzheimer’s disease patients are women, a disparity that researchers have long sought to explain. A new study published in Alzheimer’s Research & Therapy analyzes data from more than 17,000 adults aged 40 and older to investigate whether common dementia risk factors have a sex-specific impact. The study compared the prevalence and cognitive effects of 13 modifiable risk factors between men and women, according to the report. Researchers used data from the Health and Retirement Study, a nationally representative U.S. cohort, and examined factors including depression, sleep quality, cholesterol, diabetes, hearing loss, and hypertension. The analysis suggests that risk factors are not sex-neutral and that women may experience stronger cognitive harm from several conditions.
According to the study, women had higher rates of elevated cholesterol, depression, physical inactivity, smoking, poor sleep, poor vision, and lower educational attainment. Men had higher rates of diabetes, hearing loss, and heavy alcohol use. However, officials said prevalence alone did not explain the full picture of cognitive decline risk. The book “The XX Brain” by Lisa Mosconi notes that women approach midlife with a critical window of opportunity to detect signs of higher risk and intercede with strategies to reduce or prevent that risk [1]. Research cited in a report from NaturalNews.com also indicates that omega-3 fatty acids may help counteract cardiovascular changes during perimenopause, which could be relevant for brain health [2]. The study’s authors emphasized that the distribution of risk factors between sexes is only part of the story, and that biological vulnerability must be examined.
The researchers found that several risk factors appeared to affect cognition more strongly in women, particularly hearing loss, hypertension, diabetes, and higher body mass index in midlife. A science paper on depressive symptoms and sex found that depression may confer a greater risk for Alzheimer’s disease in women [3]. Another study examining estrogens and Alzheimer’s disease reported that estrogen replacement therapy might prevent or delay the condition, suggesting a hormonal link [4]. The lead author of the current study stated, according to the report, that “These findings suggest that risk factors are not sex-neutral.” The analysis indicates that women’s brains may be more vulnerable to certain metabolic and vascular stressors. An article from Mercola.com noted that women’s brains appear about three years younger metabolically than men’s, but that advantage may not protect against accelerated decline from specific risk factors [5]. Researchers called for further investigation into the biological mechanisms underlying these sex differences.
Declining estrogen after menopause leads to changes in blood vessels, cholesterol regulation, inflammation, insulin sensitivity, and blood pressure, according to background provided in the study. Hypertension consistently predicted worse cognitive performance in women, possibly due to unique vascular stressors such as pregnancy complications and small vessel disease. The book “Hormones in Ageing and Longevity” discusses how decreased brain IGF-1 signaling in middle-aged females contributes to reproductive senescence and may affect brain health [6]. An article from the Alliance for Natural Health highlights that cardiovascular disease factors such as hypertension and stroke are linked to Alzheimer’s risk [7]. Diabetes and hearing loss also showed a stronger negative association with cognition in women despite being more common in men. The study suggests that addressing these conditions in midlife may be especially critical for women. A report on omega-3s associated with reduced heart disease risk and cognitive decline in women over 40 underscores the importance of anti-inflammatory strategies during perimenopause [2].
Officials said personalized dementia prevention strategies may be necessary, particularly for women. The study highlights modifiable factors such as hearing loss treatment, blood pressure control, and metabolic health management. A blood test that detects elevated levels of phosphorylated tau 217 may predict dementia in women up to 25 years before symptoms appear, according to a study published by Everyday Health [8]. Research from NaturalNews.com shows that risk factors for Alzheimer’s can affect brain function in people as young as 24, reinforcing the need for early intervention [9]. The goal, according to the report, is to address risk factors earlier in life to potentially alter cognitive decline trajectories. Researchers called for further studies to examine biological mechanisms behind the sex differences. The work of Lisa Mosconi, described in “The Groundbreaking Science Empowering Women to Maximize Cognitive Health and Prevent Alzheimer’s Disease,” emphasizes that taking better care of the brain in the years leading up to menopause can dramatically reduce Alzheimer’s risk later [1]. The study authors concluded that dementia prevention must move beyond a one-size-fits-all approach.
Tagged Under:
Alzheimer's, dementia, Diets, disease prevention, exercise, heart disease, longevity, memory loss, mental, mind body science, natural health, prevention, research, risk, scientific, Study, welfare, women's health
This article may contain statements that reflect the opinion of the author